Non-invasive Prenatal Testing Market, By Test Type (Sequencing-based NIPT, Microarray-based NIPT, and PCR-based NIPT), By Technology, By Application, By End-user, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4211
|
Published Date
July 2025
|
Pages
400
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Non-invasive Prenatal Testing Market size was valued at US$ 4,345.67 Million in 2024, expanding at a CAGR of 9.95% from 2025 to 2032.
Non-invasive prenatal testing (NIPT) is a screening method that analyzes fetal DNA circulating in a pregnant woman’s blood to detect chromosomal abnormalities such as Down syndrome, Edwards syndrome, and Patau syndrome. This technique provides a safer alternative to invasive procedures like amniocentesis and chorionic villus sampling, significantly reducing risk to both mother and fetus. The adoption of NIPT is being driven by growing awareness of genetic disorders, advancements in sequencing technologies, and an increasing demand for early and accurate fetal health diagnosis.
The market is further supported by the expansion of prenatal care infrastructure and the rising emphasis on personalized medicine. Both healthcare providers and expectant parents prefer NIPT due to its accuracy, convenience, and non-invasive nature. Additionally, integrating NIPT with broader prenatal screening panels is enhancing its clinical value. Ethical considerations and regulatory approvals continue to influence market trends. Moreover, the increasing number of high-risk pregnancies worldwide is boosting demand for these tests, encouraging ongoing innovation in testing methodologies.
Non-invasive Prenatal Testing Market- Market Dynamics
Rising Demand for Safe, Early, and Accurate Fetal Genetic Screening Tests
The growing preference for non-invasive, risk-free testing among pregnant women is a key factor driving demand in the Non-invasive Prenatal Testing (NIPT) market. Unlike traditional invasive methods, which carry risks such as miscarriage and other complications, NIPT offers a safer alternative that many patients and clinicians prefer to avoid these potential hazards. Early and accurate detection of chromosomal abnormalities enables timely medical intervention and informed decision-making for expectant parents.
Advancements in cell-free fetal DNA analysis have significantly enhanced the sensitivity and specificity of NIPT, boosting confidence in test results. Healthcare systems worldwide are increasingly promoting safer prenatal care practices, encouraging widespread adoption of NIPT. For instance, governments in countries like the United States, the United Kingdom, and Australia have incorporated NIPT into national prenatal screening guidelines, supporting access through public health programs. The convenience of a simple blood draw, as opposed to invasive tissue collection, also contributes to its appeal. Additionally, more favorable insurance reimbursement policies across various regions support market expansion. This trend aligns with the broader societal move toward personalized medicine, emphasizing early genetic insights during pregnancy.
Non-invasive Prenatal Testing Market- Segmentation Analysis:
The Global Non-invasive Prenatal Testing Market is segmented on the basis of Test Type, Technology, Application, End-user, and Region.
The non-invasive prenatal testing (NIPT) market is segmented by test type into Sequencing-based NIPT, Microarray-based NIPT, and PCR-based NIPT, with the sequencing-based segment dominating the market. This dominance is attributed to its superior accuracy and comprehensive detection capabilities. Sequencing-based NIPT analyzes cell-free fetal DNA through next-generation sequencing (NGS), enabling the simultaneous detection of multiple chromosomal abnormalities with greater sensitivity than PCR or microarray techniques. This method can detect even low fetal DNA fractions in maternal blood, making it highly reliable for prenatal screening. Healthcare providers prefer this comprehensive approach for its ability to screen for a broad spectrum of genetic conditions with high confidence. Advances in sequencing throughput and cost reduction have further increased the accessibility and adoption of sequencing-based NIPT. The integration of sophisticated bioinformatics tools enhances clinical interpretation, reinforcing its position as the preferred routine screening option globally.
In terms of technology, the market is divided into Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, and other technologies, with NGS being the most dominant segment. NGS has revolutionized prenatal screening by providing highly accurate and detailed analysis of fetal DNA from maternal blood samples. It enables detection of a wide range of genetic abnormalities, including common trisomies such as Trisomy 21, 18, and 13, as well as microdeletions and sex chromosome aneuploidies. NGS offers higher sensitivity and specificity compared to traditional methods, significantly reducing the need for invasive confirmatory procedures like amniocentesis. Its scalability, high throughput, and cost-effectiveness have driven widespread adoption, particularly in developed countries with advanced healthcare infrastructure. Leading diagnostic companies such as Illumina, Roche, and Natera utilize NGS platforms for their NIPT products, continuously pushing innovation in this space.
Globally, regulatory bodies and health organizations including the FDA, EMA, and WHO are actively supporting the integration of NIPT into standard prenatal care due to its non-invasive nature and improved diagnostic accuracy. Many governments have incorporated NIPT into public health policies to reduce the risks associated with invasive testing and to enhance early detection of genetic disorders, contributing to the rapid growth and acceptance of sequencing-based NIPT worldwide.
Non-invasive Prenatal Testing Market- Geographical Insights
North America continues to be a key market for Non-invasive Prenatal Testing (NIPT), supported by its advanced healthcare infrastructure and early adoption of genetic technologies. The United States leads the region, driven by rising prenatal healthcare awareness and a high volume of pregnancies requiring screening. Well-established regulatory frameworks facilitate smooth product approvals, while an increasing number of healthcare providers incorporate NIPT into routine prenatal care. Awareness campaigns and medical guidelines further promote widespread testing adoption. The region also serves as a hub for innovation and is home to many leading market players. Additionally, insurance coverage in several states encourages greater uptake of NIPT.
In the U.S., demand for NIPT is growing steadily as obstetricians increasingly recommend the test for both high-risk and average-risk pregnancies. The availability of advanced sequencing technologies and efficient laboratory services has reduced testing turnaround times, enhancing accessibility. Collaborative efforts between healthcare providers and payers have improved reimbursement processes, making NIPT more affordable for patients. Major healthcare networks have integrated NIPT into standard prenatal screening protocols, reflecting a broader shift toward patient-centric care that prioritizes early, accurate, and safe fetal screening. Ongoing education initiatives for healthcare professionals continue to boost awareness and confidence in NIPT. While insurance coverage varies across states, it is generally improving. The U.S. market also benefits from strong research initiatives aimed at developing next-generation NIPT technologies.
Globally, governments are recognizing the importance of early genetic screening in improving maternal and fetal health outcomes. According to the World Health Organization (WHO), over 130 countries have implemented policies or guidelines promoting prenatal screening, including NIPT, as part of their maternal health programs. Many governments are increasing funding to expand access to NIPT, especially in regions with high rates of genetic disorders and maternal mortality. Public health initiatives in Europe, Asia-Pacific, and Latin America emphasize integrating NIPT into national prenatal care frameworks, supported by subsidies and reimbursement schemes. This global governmental support is accelerating market growth and fostering equitable access to advanced prenatal diagnostics worldwide.
Non-invasive Prenatal Testing Market- Competitive Landscape:
The competitive landscape of the Non-invasive Prenatal Testing (NIPT) market is marked by rapid technological advancements, substantial R&D investments, and strategic collaborations among leading players. Companies are expanding their testing panels to cover a broader spectrum of genetic conditions, enhancing the comprehensiveness of prenatal screening. Innovations in sequencing technologies and bioinformatics are improving test accuracy while reducing turnaround times, providing a significant competitive advantage.
Partnerships with healthcare providers and payers are crucial for increasing market penetration and facilitating insurance reimbursement. Many players are also pursuing geographic expansion into emerging markets to grow their customer base. Competitive pricing strategies and customized testing solutions further strengthen their market positions. Additionally, adherence to regulatory standards and stringent data privacy practices remain essential for maintaining trust and compliance. Mergers, acquisitions, and strategic alliances continue to intensify competition, while companies also invest in educational programs to raise awareness of the benefits of NIPT.
Recent Developments:
- In May 2025, Natera, Inc. announced the launch of an expanded NIPT panel targeting additional rare genetic conditions, enhancing prenatal screening capabilities.
- In April 2025, Illumina, Inc. released a cloud-based software upgrade for its sequencing platform, significantly improving the speed and accuracy of NIPT data analysis.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL NON-INVASIVE PRENATAL TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Illumina, Inc.
- Roche Diagnostics
- BGI Genomics
- Myriad Genetics, Inc.
- Natera, Inc.
- PerkinElmer, Inc.
- Invitae Corporation
- Thermo Fisher Scientific, Inc.
- Laboratory Corporation of America Holdings (LabCorp)
- QIAGEN N.V.
- Berry Genomics Co., Ltd.
- Agilent Technologies, Inc.
- Eurofins Scientific
- Fulgent Genetics
- Genesis Genomics
- GeneDx, Inc.
- CooperGenomics
- Congenica
- GenePlanet
- Integrated Genetics
GLOBAL NON-INVASIVE PRENATAL TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032
- Sequencing-based NIPT
- Microarray-based NIPT
- PCR-based NIPT
GLOBAL NON-INVASIVE PRENATAL TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Microarray
- Others
GLOBAL NON-INVASIVE PRENATAL TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Down Syndrome Screening
- Edwards Syndrome Screening
- Patau Syndrome Screening
- Sex Chromosome Aneuploidy Screening
- Others
GLOBAL NON-INVASIVE PRENATAL TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals & Clinics
- Diagnostic Laboratories
- Research Institutes
GLOBAL NON-INVASIVE PRENATAL TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Non-invasive Prenatal Testing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Non-invasive Prenatal Testing Market Snippet by Test Type
2.1.2. Non-invasive Prenatal Testing Market Snippet by Technology
2.1.3. Non-invasive Prenatal Testing Market Snippet by Application
2.1.4. Non-invasive Prenatal Testing Market Snippet by End-user
2.1.5. Non-invasive Prenatal Testing Market Snippet by Country
2.1.6. Non-invasive Prenatal Testing Market Snippet by Region
2.2. Competitive Insights
3. Non-invasive Prenatal Testing Key Market Trends
3.1. Non-invasive Prenatal Testing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Non-invasive Prenatal Testing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Non-invasive Prenatal Testing Market Opportunities
3.4. Non-invasive Prenatal Testing Market Future Trends
4. Non-invasive Prenatal Testing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Non-invasive Prenatal Testing Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Non-invasive Prenatal Testing Market Landscape
6.1. Non-invasive Prenatal Testing Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Non-invasive Prenatal Testing Market – By Test Type
7.1. Overview
7.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
7.1.2. Sequencing-based NIPT
7.1.3. Microarray-based NIPT
7.1.4. PCR-based NIPT
8. Non-invasive Prenatal Testing Market – By Technology
8.1. Overview
8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
8.1.2. Next-Generation Sequencing (NGS)
8.1.3. Polymerase Chain Reaction (PCR)
8.1.4. Microarray
8.1.5. Others
9. Non-invasive Prenatal Testing Market – By Application
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
9.1.2. Down Syndrome Screening
9.1.3. Edwards Syndrome Screening
9.1.4. Patau Syndrome Screening
9.1.5. Sex Chromosome Aneuploidy Screening
9.1.6. Others
10. Non-invasive Prenatal Testing Market – By End-user
10.1. Overview
10.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
10.1.2. Hospitals & Clinics
10.1.3. Diagnostic Laboratories
10.1.4. Research Institutes
11. Non-invasive Prenatal Testing Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Non-invasive Prenatal Testing Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Non-invasive Prenatal Testing Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Non-invasive Prenatal Testing Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Non-invasive Prenatal Testing Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Non-invasive Prenatal Testing Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Non-invasive Prenatal Testing Industry
12.1. Competitive Dashboard
12.1.1. Competitive Benchmarking
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Illumina, Inc.
12.2.2. Roche Diagnostics
12.2.3. BGI Genomics
12.2.4. Myriad Genetics, Inc.
12.2.5. Natera, Inc.
12.2.6. PerkinElmer, Inc.
12.2.7. Invitae Corporation
12.2.8. Thermo Fisher Scientific, Inc.
12.2.9. Laboratory Corporation of America Holdings (LabCorp)
12.2.10. QIAGEN N.V.
12.2.11. Berry Genomics Co., Ltd.
12.2.12. Agilent Technologies, Inc.
12.2.13. Eurofins Scientific
12.2.14. Fulgent Genetics
12.2.15. Genesis Genomics
12.2.16. GeneDx, Inc.
12.2.17. CooperGenomics
12.2.18. Congenica
12.2.19. GenePlanet
12.2.20. Integrated Genetics
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
